Tuberculosis control: The relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance

Epidemiologic Reviews

Volumn 18, Issue 1, 1996, Pages 52-63

  Kaye, Katherine ^a   Frieden, Thomas R ^a,b  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ECONOMIC ASPECT; EPIDEMIC; HUMAN; INFECTION RISK; MASS SCREENING; MIGRATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0029807273     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a017916     Document Type: Review

References (94)

1. Expanded tuberculosis surveillance and tuberculosis morbidity - United States, 1993. MMWR Morb Mortal Wkly Rep 1994;43:361-6.
2. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-6.
3. McKenna MT, McCray E, Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med 1995;332:1071-6.
4. Joseph S. Tuberculosis, again. (Editorial). Am J Public Health 1993;83:647-8.
5. TB Programme. TB, a global emergency: WHO report on the TB epidemic. Geneva, Switzerland: World Health Organization, 1994. (WHO/TB/94-177.)
6. Reported tuberculosis in the United States, 1993. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
7. Wharton M, Chorba TL, Vogt RL, et al. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990;39(RR-13):1-43.
8. Gangadharam PRJ. Drug resistance in tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York, NY: Marcel Dekker, 1993:293-328.
9. Rieder HL, Cauthen GM, Comstock GW, et al. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989;11: 79-98.
10. Nardell EA. Pathogenesis of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York, NY: Marcel Dekker, 1993: 103-22.
11. Grosset JH. Bacteriology of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York, NY: Marcel Dekker, 1993:49-74.
12. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990;65:6-24.
13. Houk VN, Kent DC, Baker JH, et al. The Byrd Study: in-depth analysis of a micro-outbreak of tuberculosis in a closed environment. Arch Environ Health 1968;16:4-6.
14. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and Centers for Disease Control and Prevention. Am J Respir Crit Care Med 1994;149:1359-74.
15. Daniel TM, Ellner JJ. Immunology of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York, NY: Marcel Dekker, 1993:75-101.
16. Murray C, Styblo K, Rouillon A. Tuberculosis. In: Jamison DT, Mosely WH, Measham AR, et el., eds. Disease control priorities in developing countries. New York, NY: Oxford University Press (for the World Bank), 1993:233-59.
17. Comstock GW, Cauthen GM. Epidemiology of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York, NY: Marcel Dekker, 1993:23-48.
18. Starke JR, Jacobs RF, Jereb J. Resurgence of tuberculosis in children. J Pediatr 1992;120:839-55.
19. The use of preventive therapy for tuberculous infection in the United States. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1990;39(RR-8):9-12.
20. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330: 1703-9.
21. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330:1710-16.
22. Nardell E, McInnis B, Thomas B, et al. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med 1986;315:1570-5.
23. Small PM, Shafer RW, Hopewell PO, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328:1137-44.
24. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
25. Shennan DH. Resistance of tubercle bacilli to isoniazid, PAS and streptomycin, related to history of previous treatment. Tubercle 1964;45:1-6.
26. Costello HD, Caras GJ, Snider DE Jr. Drug resistance among previously treated tuberculosis patients: a brief report. Am Rev Respir Dis 1980;121:313-16.
27. Tuberculosis in New York City, 1994: information summary. New York, NY: New York City Department of Health, Bureau of Tuberculosis Control, 1995.
28. Styblo K, Meijer J, Sutherland I. Tuberculosis Surveillance Research Unit report no. 1: the transmission of tubercle bacilli; its trend in a human population. Bull Int Union Tuberc 1969;42:1-104.
29. Styblo K. The relationship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc 1985;60:117-19.
30. Rieder HL. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Disease 1995;76:114-21.
31. Inderlied CB. Antimycobacterial susceptibility testing: present practices and future trends. Eur J Microbiol Infect Dis 1994; 13:980-93.
32. Porter JDH, McAdam KPWJ. The re-emergence of tuberculosis. Annu Rev Public Health 1994;15:303-23.
33. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9.
34. Tuberculosis morbidity - United States, 1994. MMWR Morb Mortal Wkly Rep 1995;44:387-9, 395.
35. Tuberculosis morbidity - United States, 1995. MMWR Morb Mortal Wkly Rep 1996;45:365-70.
36. Fujiwara PI, Frieden TR. Tuberculosis epidemiology and control in the inner city. In: Rom WN, Garay SM, eds. Tuberculosis. Boston, MA: Little Brown, 1996:99-111.
37. Tuberculosis statistics in the United States - 1992. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
38. Doster B, Caras GJ, Snider DE. A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A United States Public Health Service cooperative study. Am Rev Respir Dis 1976;113:419-25.
39. Kopanoff DE, Kilburn JO, Glassroth JL, et al. A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. A United States Public Health Service cooperative study. Am Rev Respir Dis 1978; 118:835-42.
40. Outbreak of multidrug-resistant tuberculosis - Texas, California, and Pennsylvania. MMWR Morb Mortal Wkly Rep 1990; 39:369-72.
41. Interstate outbreak of multidrug-resistant tuberculosis involving children - California, Montana, Nevada, Utah. MMWR Morb Mortal Wkly Rep 1983;32:516-18.
42. Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility - Michigan. MMWR Morb Mortal Wkly Rep 1991; 40:129-31.
43. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991;40: 585-91.
44. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992;117:191-6.
45. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514-21.
46. Snider DE Jr, Dooley SW. Nosocomial tuberculosis in the AIDS era with an emphasis on multidrug-resistant disease. Heart Lung 1993;22:365-9.
47. Telzac EE, Sepkowitz K, Alpert P, et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med 1995;333:907-11.
48. Park MM, Davis AL, Schluger NW, et al. Outcome of MDR-TB patients, 1983-1993: prolonged survival with appropriate therapy. Am J Respir Crit Care Med 1996;153: 317-24.
49. National action plan to combat multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 1992;41 (RR-11):5-48.
50. Raviglione MC, Sudre P, Rieder HL, et al. Secular trends of tuberculosis in western Europe. Bull World Health Organ 1993;71:297-306.
51. Hargreaves J. Tuberculosis notifications in Australia, 1992. Commun Dis Intell 1994;18:330-7.
52. Raviglione MC, Rieder HL, Styblo K, et al. Tuberculosis trends in eastern Europe and the former USSR. Tuber Lung Dis 1994;75:400-16.
53. Sudre P, ten Dam HG, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992; 70;149-59.
54. Tuberculosis, HIV on collision course in Asia. World Health Organization, Office of Information, press release, August 10, 1994. (WHO/63).
55. Kleeborg HH, Olivier MS, eds. A world atlas of initial drug resistance. 2nd rev ed. Atlanta, GA: Centers for Disease Control, 1984.
56. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-64.
57. Arno PS, Murray CJL, Bonuck K, et al. The economic impact of tuberculosis in hospitals in New York City: a preliminary analysis. J Law Med Ethics 1993;21:317-23.
58. The global burden of disease, 1990. In: World development report, 1993: investing in health. New York, NY: Oxford University Press, 1993: appendix B.
59. The HIV pandemic: status and trends. In: Mann J, Tarantola DJM, Netter TW. AIDS in the world, 1992. Cambridge, MA: Harvard University Press, 1992:11-108.
60. Barnes PF, Bloch AB, Davidson PT, et al. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644-50.
61. Cantwell MF, Snider DE, Cauthen GM, et al. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272:535-9.
62. Tuberculosis and acquired immunodeficiency syndrome - New York City. MMWR Morb Mortal Wkly Rep 1987;36: 785-90, 795.
63. Chaisson RE, Schecter GF, Theuer CP, et al. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy, and survival. Am Rev Respir Dis 1987;136:570-4.
64. Selwyn PA, Sckell BM, Alcabes P, et al. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992;268:504-9.
65. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545-50.
66. Kramer F, Modilevsky T, Waliany AR, et al. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 1990;89:451-6.
67. Flora GS, Modilevsky T, Antoniskis D, et al. Undiagnosed tuberculosis in patients with human immunodeficiency virus infection. Chest 1990;98:1056-9.
68. Onorato IM, McCray E. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis 1992;165:87-92.
69. Buskin SE, Gale J, Weiss N, et al. Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990. Am J Public Health 1994;84:1750-6.
70. Powell KE, Meador MP, Farer LS. Foreign-bom persons with tuberculosis in the United States. Am J Public Health 1981; 71:1223-7.
71. Ziv TA, Lo B. Denial of care to illegal immigrants: Proposition 187 in California. N Engl J Med 1995;332:1095-8.
72. Barr RG, Menzies R. The effect of war on tuberculosis: results of a tuberculin survey among displaced persons in El Salvador and a review of the literature. Tuber Lung Dis 1994;75:251-9.
73. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745-9.
74. McAdam JM, Brickner PW, Scharer LL, et al. The spectrum of tuberculosis in a New York City men's shelter clinic (1982-1988). Chest 1990;97:798-805.
75. Hoge CW, Reichler MR, Dominiquez EA, et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994;331:643-8.
76. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. MMWR Morb Mortal Wkly Rep 1992;41:507-9.
77. Prevention and control of tuberculosis in correctional institutions: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1989;38:313-20, 325.
78. Harpham T, Stephens C. Urbanization and health in developing countries. World Health Stat Q 1991;44:62-9.
79. Bradley DJ, Stephens C, Harpham T, et al. A review of environmental health impacts in developing country cities. Washington, DC: The World Bank, 1992.
80. Hamburg MA, Frieden TR. Tuberculosis transmission in the 1990s. (Editorial). N Engl J Med 1994;330:1750-1.
81. Reichman LB. The U-shaped curve of concern. (Editorial). Am Rev Respir Dis 1991;144:741-2.
82. Menzies D, Fanning A, Yuan L, et al. Tuberculosis among health care workers. N Engl J Med 1995;332:92-8.
83. McAnulty JM, Fleming DW, Hawley MA, et al. Missed opportunities for tuberculosis prevention. Arch Intern Med 1995;155:713-16.
84. TB Programme. DOTS stops TB at the source: WHO report on the tuberculosis epidemic, 1995. Geneva, Switzerland: World Health Organization, 1995. (WHO/TB/95.183).
85. Weis SE, Slocum PC, Biais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994;330:1179-84.
86. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: we can't afford not to try it. N Engl J Med 1993;328:376-8.
87. New York City's tuberculosis cases decline but still highest in nation. New York, NY: New York City Department of Health, press release, March 22, 1996.
88. Comstock GW, Woolpert SF. Preventive treatment of untreated, nonactive tuberculosis in an Eskimo population. Arch Environ Health 1972;25:333-7.
89. Management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 1992;41(RR-11): 61-71.
90. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Morb Mortal Wkly Rep 1994;43(RR-13):1-132.
91. Tuberculosis in New York City, 1992: information summary. New York, NY: New York City Department of Health, Bureau of Tuberculosis Control, 1993.
92. Tuberculosis in New York City, 1993: information summary. New York, NY: New York City Department of Health, Bureau of Tuberculosis Control, 1994.
93. Tuberculosis in New York City, 1995: information summary. New York, NY: New York City Department of Health, Bureau of Tuberculous Control, 1996.
94. Comstock GW. Tuberculosis: is the past once again prologue? Am J Public Health 1994;84:1729-31.